CRISPR Therapeutics News - CRSP

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
CRISPR Therapeutics AG CRSP NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 63.93 0.00 0.00 0.00 63.93 08:13:55
more quote information »

Recent News

Date Time Source Heading
5/27/202016:35EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202016:33EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202008:30GLOBECRISPR Therapeutics to Participate in Upcoming Investor..
5/21/202016:38EDGARStatement of Changes in Beneficial Ownership (4)
5/21/202016:36EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202016:35EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/15/202008:30GLOBECRISPR Therapeutics Announces Presentations at the American..
5/14/202009:12EDGARCurrent Report Filing (8-k)
5/14/202009:02GLOBENew Data for Investigational CRISPR/Cas9 Gene-Editing..
5/13/202016:39EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202012:49DJNCRISPR Therapeutics, Vertex Up After CTX001 Gets RMAT..
5/11/202009:13EDGARCurrent Report Filing (8-k)
5/11/202009:00GLOBECRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA..
5/07/202008:00GLOBECRISPR Therapeutics to Present at the Bank of America..
4/28/202016:58EDGARQuarterly Report (10-q)
4/28/202016:51EDGARCurrent Report Filing (8-k)
4/28/202016:45GLOBECRISPR Therapeutics Provides Business Update and Reports..
4/24/202016:12EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/24/202016:10EDGARProxy Statement (definitive) (def 14a)
4/10/202011:01EDGARAmended Small Company Offering and Sale of Securities..
4/09/202016:43EDGARSmall Company Offering and Sale of Securities Without..
3/31/202017:01EDGARProxy Statement - Notice of Shareholders Meeting..
3/31/202016:09EDGARCurrent Report Filing (8-k)
3/12/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
3/12/202016:21EDGARStatement of Changes in Beneficial Ownership (4)
3/12/202016:21EDGARStatement of Changes in Beneficial Ownership (4)
3/12/202016:21EDGARStatement of Changes in Beneficial Ownership (4)
3/12/202016:11EDGARStatement of Changes in Beneficial Ownership (4)
3/09/202016:14EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202016:27EDGARStatement of Changes in Beneficial Ownership (4)
2/26/202016:11EDGARCurrent Report Filing (8-k)
2/26/202016:05GLOBECRISPR Therapeutics Proposes Changes to the Board of..
2/14/202016:22EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
2/13/202016:06EDGARAmended Statement of Ownership (sc 13g/a)
2/12/202016:15EDGARAnnual Report (10-k)
2/12/202016:06EDGARCurrent Report Filing (8-k)
2/12/202016:05GLOBECRISPR Therapeutics Provides Business Update and Reports..
2/12/202015:20EDGARStatement of Ownership (sc 13g)
2/12/202006:04EDGARStatement of Ownership (sc 13g)
2/04/202016:20EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/29/202016:17EDGARCurrent Report Filing (8-k)
1/24/202016:09EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/10/202016:50EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/06/202016:05GLOBECRISPR Therapeutics to Present at the Goldman Sachs 12th..
12/27/201916:07EDGARCurrent Report Filing (8-k)
12/18/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
12/16/201907:02EDGARCurrent Report Filing (8-k)
12/05/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
12/05/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
12/05/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »
Your Recent History
NASDAQ
CRSP
CRISPR The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200528 12:58:39